Puma Biotechnology Inc's Customers Performance

Name: Puma Biotechnology Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

PBYI

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


PBYI's Source of Revenues		During the corresponding time, Puma Biotechnology Inc saw a revenue deteriorated by -2.59 % year on year, sequentially revenue fell by -40.61 %. While revenue at the Puma Biotechnology Inc 's corporate clients • List of PBYI Customers

for the same period Puma Biotechnology Inc revnue deteriorated by -2.59 % year on year, sequentially revenue fell by -40.61 %.

• List of PBYI Customers

Puma Biotechnology Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Puma Biotechnology Inc's Comment on Sales, Marketing and Customers

Puma Biotechnology, Inc. develops and commercializes cancer treatment products, including NERLYNX for certain HER2-positive breast cancers and alisertib, a selective inhibitor targeting Aurora Kinase A. Alisertib has potential applications in hormone receptor-positive breast cancer, triple negative breast cancer, and small cell lung cancer. The company serves patients with early stage and metastatic HER2-positive breast cancer, small cell lung cancer, and hormone receptor-positive breast cancer. Puma Biotechnology relies on international third-party sub-licensees for commercialization outside the United States. Takeda Pharmaceutical Company Limited is identified as a customer and market partner in the company's filings.

Puma Biotechnology Inc’s Comment on Sales, Marketing and Customers

PBYI's Stock Performance relative to it's Customers

PBYI's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Puma Biotechnology Inc	478.45	227.18	24.38	179
SUBTOTAL	0.00	0.00	0.00	-

Sources: Puma Biotechnology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Puma Biotechnology Inc’s corporate clients.
For your research, we’ve provided 9 tables on Puma Biotechnology Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.